Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies as Senolytics

Velabs Therapeutics announced that it has entered into an exclusive licence agreement with alytas therapeutics for the development & commercialization of alytas’ antibodies in the field of senescence..

Signant Health Partners with Propeller Health to Gather Accurate Data on Asthma and COPD Medication Use

Signant Health announced a partnership to connect TrialMax Propeller Health's digital health platform for asthma and COPD (chronic obstructive pulmonary..

Novartis announces partnership with Amazon to digitally transform operations

Novartis work with Amazon Web Services to increase efficiencies across its manufacturing, supply chain and delivery operations.

BeiGene obtains certain rights for Leap Therapeutics cancer drug

Chinese biopharmaceutical firm BeiGene has agreed to exclusive rights to develop and commercialise Leap Therapeutics’ cancer drug DKN-01 in the Asia Pacific region, excluding Japan.

Arctoris Ltd Successfully Moves into its New Global Headquarters in Oxford, UK

Arctoris Ltd opened the doors to its new global headquarters and state-of-the-art research and development (R&D) facility in Oxford, UK.

Catalent Completes Purchase of Biologics Fill-Finish and Oral Solid Dose Facility in Anagni, Italy

Catalent announced the completion of the purchase of Bristol-Myers Squibb’s biologics, sterile, and product manufacturing and packaging facility in Anagni, Italy.